P3‐032: Identification of Predictors of Disease Progression in an Amyloid‐Beta 42 (Aβ42)‐Positive, Prodromal Alzheimer’s Disease Cohort: Analysis of the Scarlet Road Study | Zendy

Sun Shuguang | Zendy; Model Fabian | Zendy; Nikolcheva Tania | Zendy; Lasser Robert A. | Zendy

Premium

P3‐032: Identification of Predictors of Disease Progression in an Amyloid‐Beta 42 (Aβ42)‐Positive, Prodromal Alzheimer’s Disease Cohort: Analysis of the Scarlet Road Study

Author(s) -

Sun Shuguang,

Model Fabian,

Nikolcheva Tania,

Lasser Robert A.

Publication year - 2016

Publication title -

alzheimer's and dementia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.713

H-Index - 118

eISSN - 1552-5279

pISSN - 1552-5260

DOI - 10.1016/j.jalz.2016.06.1689

Subject(s) - hazard ratio , medicine , cohort , proportional hazards model , placebo , disease , clinical endpoint , biomarker , cohort study , clinical trial , confidence interval , pathology , biochemistry , chemistry , alternative medicine

Alzheimer Center and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, Netherlands; 2 University of Leicester, Leicester, United Kingdom; 3 Global Innovative Pharma Business – Clinical Sciences Pfizer, Paris, France; Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; 5 VU University Medical Center, Amsterdam, Netherlands. Contact e-mail: l.vermunt@vumc.nl

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research